Digifab Injection, Powder, Lyophilized, For Solution
Product Images NDC 50633-120

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Digifab (NDC 50633-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Btg International Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Digifab 01

Digifab 01
DigiFab 40 mg injection powder label for intravenous use, featuring ovine digoxin immune fab as the active ingredient. The label indicates the product is a sterile lyophilized powder, to be reconstituted with sterile water for injection. Manufactured and distributed by BTG International Inc., the package contains one vial. Storage instructions and trademark information are included.*
FDA Label Image

Carton Label (Digifab 02)

Carton Label (Digifab 02)
Label for DigiFab 40 mg injection, lyophilized powder for solution, ovine digoxin immune fab. The label includes storage instructions (store at 2° to 8°C, do not freeze), directions indicating intravenous injection use after reconstitution, manufacturer and distributor BTG International Inc., West Conshohocken, PA, and a barcode with NDC 50633-120-12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.